Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides.
暂无分享,去创建一个
R. Pohl | Michal Hocek | T. Cihlar | G. Birkuš | I. Votruba | L. Slavětínská | Gina Bahador | Pavla Perlíková | Aurélie Bourderioux | Petr Nauš
[1] M. Rowley,et al. Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase. , 2012, Bioorganic & medicinal chemistry.
[2] I. Pichová,et al. Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines. , 2011, Journal of medicinal chemistry.
[3] R. Pohl,et al. Sugar-Modified Derivatives of Cytostatic 6-(Het)aryl-7-deazapurine Nucleosides: 2′-C-Methylribonucleosides, Arabinonucleosides and 2′-Deoxy-2′-fluoroarabinonucleosides. , 2011 .
[4] R. Pohl,et al. Phosphoramidate pronucleotides of cytostatic 6-aryl-7-deazapurine ribonucleosides. , 2011, Bioorganic & medicinal chemistry.
[5] C. Cameron,et al. Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. , 2010, Journal of medicinal chemistry.
[6] Helena Zábranská,et al. CycloSal‐phosphate Pronucleotides of Cytostatic 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Cytostatic Activity, and Inhibition of Adenosine Kinases , 2010, ChemMedChem.
[7] R. Pohl,et al. 6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents. , 2010, Journal of medicinal chemistry.
[8] C. K. Chu,et al. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase. , 2008, Journal of medicinal chemistry.
[9] C. Galmarini,et al. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. , 2008, Current medicinal chemistry.
[10] F. Seela,et al. 7-Functionalized 7-deazapurine β-d and β-l-ribonucleosides related to tubercidin and 7-deazainosine: glycosylation of pyrrolo[2,3-d]pyrimidines with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d or β-l-ribofuranose , 2007 .
[11] Kanyawim Kirtikara,et al. Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.
[12] P. Čapek,et al. Cross-coupling reactions of unprotected halopurine bases, nucleosides, nucleotides and nucleoside triphosphates with 4-boronophenylalanine in water. Synthesis of (purin-8-yl)- and (purin-6-yl)phenylalanines. , 2006, Organic & biomolecular chemistry.
[13] M. Otto,et al. Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides. , 2005, Journal of medicinal chemistry.
[14] Giovanni Migliaccio,et al. A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties , 2004, Antimicrobial Agents and Chemotherapy.
[15] P. D. Cook,et al. Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. , 2004, Journal of medicinal chemistry.
[16] Yoshinori Yamamoto,et al. Copper‐Catalyzed Synthesis of N‐Unsubstituted 1,2,3‐Triazoles from Nonactivated Terminal Alkynes , 2004 .
[17] W. Waud,et al. Purine nucleoside antimetabolites in development for the treatment of cancer. , 2004, Current opinion in investigational drugs.
[18] Quanlai Song,et al. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. , 2004, Journal of medicinal chemistry.
[19] A. M. Riley,et al. Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction. , 2003, Journal of medicinal chemistry.
[20] M. Erion,et al. Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides. , 2003, Journal of medicinal chemistry.
[21] P. Gannett,et al. Efficient one-step Suzuki arylation of unprotected halonucleosides, using water-soluble palladium catalysts. , 2003, The Journal of organic chemistry.
[22] M. Otto,et al. Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture , 2003, Antimicrobial Agents and Chemotherapy.
[23] J. Mackey,et al. Nucleoside analogues and nucleobases in cancer treatment. , 2002, The Lancet. Oncology.
[24] S. Johnson,et al. Nucleoside analogues in the treatment of haematological malignancies , 2001, Expert opinion on pharmacotherapy.
[25] Michal Hocek,et al. Cytostatic 6-Arylpurine Nucleosides III. Synthesis and Structure-Activity Relationship Study in Cytostatic Activity of 6-Aryl-, 6-Hetaryl- and 6-Benzylpurine Ribonucleosides , 2001 .
[26] S. Johnson,et al. Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies , 2000 .
[27] M. Erion,et al. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. , 2000, Journal of medicinal chemistry.
[28] Michal Hocek,et al. Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids. , 2000, Journal of medicinal chemistry.
[29] C. Martini,et al. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. , 1998, Journal of medicinal chemistry.
[30] F. Seela,et al. The DNA-stabilising nucleoside 7-iodo-2′-deoxytubercidin: its structure in the solid state and in solution , 1996 .
[31] K. Nebel,et al. A novel synthesis of sulfamoyl nucleosides , 1994 .
[32] D. Scudiero,et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.
[33] F. Seela,et al. Liquid–liquid and solid–liquid phase-transfer glycosylation of pyrrolo[2,3-d]pyrimidines: stereospecific synthesis of 2-deoxy-β-D-ribofuranosides related to 2′-deoxy-7-carbaguanosine , 1988 .
[34] R. K. Robins,et al. A facile synthesis of tubercidin and related 7-deazapurine nucleosides via the stereospecific sodium salt glycosylation procedure , 1987 .
[35] H. G. Howell,et al. Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil (.beta.-FIAU) and 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)thymine (.beta.-FMAU) , 1985 .
[36] E. De Clercq,et al. Antiviral activity of C-5 substituted tubercidin analogues. , 1984, Journal of medicinal chemistry.
[37] A. Cook,et al. Synthesis of the Natural Product 5'-Deoxy-5-iodotubercidin and Related Halogenated Analogs , 1984 .
[38] R. K. Robins,et al. Pyrrolopyrimidine nucleosides. 3. The total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives. , 1969, Journal of the American Chemical Society.
[39] E. Reich,et al. BIOLOGICAL AND BIOCHEMICAL PROPERTIES OF THE ANALOGUE ANTIBIOTIC TUBERCIDIN. , 1964, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Suzuki,et al. A new antibiotic, tubercidin. , 1957, The Journal of antibiotics.